Quarterly report pursuant to Section 13 or 15(d)

CONDENSED BALANCE SHEETS

v3.5.0.2
CONDENSED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2016
Dec. 31, 2015
Current assets:    
Cash $ 16,489 $ 7,857
Receivables 5,908 4,213
Prepaid expenses and other current assets 278 174
Total current assets 22,675 12,244
Property and equipment, net 860 1,043
Total assets 23,535 13,287
Current liabilities:    
Accounts payable 4,954 4,158
Accrued clinical trials expenses 1,248 341
Other accrued liabilities 516 354
Total current liabilities 6,718 4,853
Warrant liabilities 1,555 1,444
Total liabilities 8,273 6,297
Commitments and contingencies
Stockholders’ equity:    
Common stock, at amounts paid-in 297,855 297,828
Additional paid-in capital 24,044 23,261
Accumulated deficit (306,637) (314,099)
Total stockholders’ equity 15,262 6,990
Total liabilities and stockholders’ equity $ 23,535 $ 13,287